Aldatu Biosciences, Inc.

Aldatu Biosciences develops molecular diagnostic assays using its proprietary PANDAA (Pan Degenerate Amplification and Adaptation) platform to detect infectious diseases including SARS-CoV-2, HIV drug resistance, and viral hemorrhagic fevers through RT-PCR technology. The company's technology is designed to detect pathogens in genomically variable regions without requiring assay redesign when new viral variants emerge.